Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 5 of 10
Arcellx, Inc.
Shares:14.0K
Value:$915.9K
REGENERON PHARMACEUTICALS, INC.
Shares:1.4K
Value:$863.2K
G52443101
Shares:75.0K
Value:$841.5K
AGIOS PHARMACEUTICALS, INC.
Shares:27.9K
Value:$817.5K
00439U104
Shares:343.5K
Value:$783.2K
Kezar Life Sciences, Inc.
Shares:147.4K
Value:$719.3K
ARROWHEAD PHARMACEUTICALS, INC.
Shares:56.3K
Value:$717.3K
SpringWorks Therapeutics, Inc.
Shares:15.0K
Value:$662.0K
Structure Therapeutics Inc.
Shares:35.6K
Value:$616.6K
BIOGEN INC.
Shares:4.5K
Value:$615.8K
iTeos Therapeutics, Inc.
Shares:101.1K
Value:$603.5K
Natera, Inc.
Shares:4.3K
Value:$601.0K
Zymeworks Inc.
Shares:50.0K
Value:$595.5K
Lexeo Therapeutics, Inc.
Shares:170.4K
Value:$591.5K
49721T507
Shares:194.7K
Value:$585.9K
Spero Therapeutics, Inc.
Shares:801.3K
Value:$576.9K
Biohaven Ltd.
Shares:22.6K
Value:$544.3K
Protara Therapeutics, Inc.
Shares:122.7K
Value:$522.7K
97717Y527
Shares:10.0K
Value:$503.3K
G0131Y100
Shares:47.1K
Value:$502.1K